
Cleerly, Inc. is an Artificial Intelligence (AI) driven precision diagnostic assistance solution with the goal of preventing heart attacks. Cleerly’s technology goes beyond traditional measures of heart disease by delivering comprehensive quantification and characterization of atherosclerosis, or plaque buildup, in each of the heart’s arteries. Cleerly performs non-invasive analysis of heart health using Cleerly’s AI and Machine Learning driven Coronary Computed Tomography Angiography (CCTA) analytics process to provide additional inputs to clinicians and help drive more informed decision about a patient’s treatment pathway.
Security Advisory: Cleerly has completed a review regarding the PHP2Shell vulnerability. Our environments do not run affected PHP versions, and all customer data remains secure.